Literature DB >> 17537389

Psychiatric manifestations in systemic lupus erythematosus.

Ljudmila Stojanovich1, Gisele Zandman-Goddard, Sanja Pavlovich, Natasa Sikanich.   

Abstract

Psychiatric abnormalities are common in systemic lupus erythematosus (SLE) with a prevalence of 17% to 75%, reflecting different methods of patient selection and assessment, the different professional orientation of clinicians, and lack of an accepted consensus for diagnosing active neuropsychiatric lupus (NPSLE). The psychiatric syndromes included in the ACR Neuropsychiatric Lupus Nomenclature Committee criteria are cognitive dysfunction, acute confusional state (delirium), anxiety disorder, mood disorder, and psychosis. In SLE patients, identification of psychiatric phenomena and the generation of a differential diagnosis are crucial. Possible mechanisms include vascular injury and pathogenic antibodies. Treatment strategies are based on small case studies. The purpose of this review is to discuss clinical manifestations, pathogenesis and the present therapeutic options in psychiatric lupus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537389     DOI: 10.1016/j.autrev.2007.02.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  18 in total

1.  Prevalence and risk factors of anxiety and depression in patients with systemic lupus erythematosus in Southwest China.

Authors:  Xia Xie; Dongmei Wu; Hong Chen
Journal:  Rheumatol Int       Date:  2016-08-31       Impact factor: 2.631

2.  Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience.

Authors:  Zahra Zakeri; Mansoor Shakiba; Behzad Narouie; Nikol Mladkova; Mohammad Ghasemi-Rad; Alireza Khosravi
Journal:  Rheumatol Int       Date:  2011-01-21       Impact factor: 2.631

3.  Mental disorders in systemic lupus erythematosus: a cohort study.

Authors:  Heidi Fernandez; Andrea Cevallos; Ruth Jimbo Sotomayor; Fernando Naranjo-Saltos; Diego Mera Orces; Efrain Basantes
Journal:  Rheumatol Int       Date:  2019-08-20       Impact factor: 2.631

4.  Secondary psychoses: an update.

Authors:  Matcheri S Keshavan; Yoshio Kaneko
Journal:  World Psychiatry       Date:  2013-02       Impact factor: 49.548

5.  Intracranial hypertension syndrome in systemic lupus erythematosus: clinical analysis and review of the literature.

Authors:  Zheng Xue; Xuezhen Wang; Fei Liu; Shaoxian Hu; Suiqiang Zhu; Suming Zhang; Bitao Bu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

6.  Depression is an early disease manifestation in lupus-prone MRL/lpr mice.

Authors:  Hua-Xin Gao; Sean R Campbell; Min-Hui Cui; Pu Zong; Jong Hee-Hwang; Maria Gulinello; Chaim Putterman
Journal:  J Neuroimmunol       Date:  2009-01-03       Impact factor: 3.478

Review 7.  Systemic lupus erythematosus involving the nervous system: presentation, pathogenesis, and management.

Authors:  Julia J Rhiannon
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

Review 8.  Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus.

Authors:  Simone Appenzeller; G Bruce Pike; Ann E Clarke
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

9.  A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.

Authors:  Ece Ercan; Carson Ingo; Oranan Tritanon; Cesar Magro-Checa; Alex Smith; Seth Smith; Tom Huizinga; Mark A van Buchem; Itamar Ronen
Journal:  Neuroimage Clin       Date:  2015-05-16       Impact factor: 4.881

10.  Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus.

Authors:  Meggan Mackay; Chris C Tang; Bruce T Volpe; Cynthia Aranow; Paul J Mattis; Ricki A Korff; Betty Diamond; David Eidelberg
Journal:  Lupus Sci Med       Date:  2015-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.